Win Rutherfurd

Experience: Debt Offerings: Represented ARKO Corp. in its Rule 144A offering of $450 million of its 125% Senior Notes due 2029.; Represented TopBuild Corp. in its Rule 144A offering of $400 million of its 5.625% Senior Notes due 2026.; Represented Raymond James as placement agent in connection with $115 million private offering of senior secured notes by a private real estate company.; Represented investment banks in connection with a registered offering of an aggregate of $9 billion of senior notes, an aggregate of 1.5 billion of senior notes and an aggregate of 1.050 billion of senior notes, relating to an acquisition by the issuer.; Represented an issuer in connection with its registered offering of an aggregate of $2 billion of senior notes.; Represented investment banks in connection with a $1.75 billion Rule 144A /Regulation S offering of senior notes and a concurrent cash tender offer for $600 million of its outstanding senior notes.; Represented an investment bank in 350 million Rule 144A /Regulation S offering of senior guaranteed notes relating to spin-off of a transportation system business from a public company.; Represented an investment bank regarding consent solicitation by an insurance company from the holders of its certain of its outstanding notes to certain amendments under the indenture governing such notes.; Represented a financial institution relating to its $40 billion medium-term-notes program for 2017.; Equity Offerings: Represented Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) in its $450 million initial public offering.; Represented Enlivex Therapeutics (Nasdaq: ENLV) in connection with a $46 million underwritten offering of ordinary shares.; Represented The Music Acquisition Corporation (NYSE: TMAC) in its $200 million initial public offering.; Represented Barclays Capital Inc. in connection with the $115 million initial public offering of Motion Acquisition Corp. (Nasdaq: MOTN).; Represented H.C. Wainwright & Co. as underwriter in connection with a $30 million offering of American Depositary Shares by BioLineRx Ltd. (Nasdaq: BLRX).; Represented Raymond James as placement agent in connection with a $90 million offering of 7.00% Series C Cumulative Redeemable Preferred Stock by a REIT.; Represented Raymond James as placement agent in connection with a $125 million private offering of preferred membership interests by a private real estate company.; Represented Opko Health, Inc. (Nasdaq: OPK) in connection with a $75 million underwritten offering of common stock.; Represented a public company in a $776 million block trade by certain selling stockholders affiliated with a private equity firm, in order to sell stock obtained in connection with the sale of a portfolio company to the public company.; Represented an investment bank relating to a secondary offering of stock of a U.S. listed foreign private issuer.; Represented an investment bank in $124.8 million initial public offering of a financial institution.; Represented an insurance company in its $98 million Up-C initial public offering.; Represented issuers and investment banks in connection with At-The-Market offering programs.; Represented issuers and purchasers in connection with equity line programs.; The above representations were handled by Mr. Rutherfurd prior to his joining Greenberg Traurig, P.A.; In-House Experience: Ongoing representation of several NYSE- and Nasdaq-traded public companies; Legal Secondee to Prime Brokerage of a financial institution in 2018